• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外耳道炎:局部使用环丙沙星与局部使用土霉素、多粘菌素B、氢化可的松联合治疗的临床比较

Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.

作者信息

Arnes E, Dibb W L

机构信息

Ostfold Central Hospital, Sarpsborg/Fredrikstad, Norway.

出版信息

Curr Med Res Opin. 1993;13(3):182-6. doi: 10.1185/03007999309111548.

DOI:10.1185/03007999309111548
PMID:8222746
Abstract

Thirty patients with otitis externa were included in a prospective, randomized, parallel group comparison study. Treatment regimens used were ciprofloxacin (2 mg/ml) as ear drops twice daily or drops containing oxytetracycline (5 mg/ml) polymyxin B (10,000 units/ml) and hydrocortisone (15 mg/ml) twice daily for 7 days. Evaluation was by clinical signs and symptoms and bacteriological findings from ear swabs prior to and 3 and 8 days after start of therapy, together with long-term follow-up if necessary. Sixteen patients were included in the ciprofloxacin and 14 in the combined antibiotic group. Six of 16 and 7 of 14 initial swabs, respectively, contained Pseudomonas aeruginosa. Mixed Gram-negative and Gram-positive pathogens were found in 3 patients in the ciprofloxacin group. All Gram-negative isolates were sensitive to ciprofloxacin. Microbiological evaluation showed rapid eradication of all bacterial pathogens in the ciprofloxacin group with 1 persistence of Candida albicans but eradication of Staphylococcus aureus in the same ear with marked clinical improvement. There was 1 case of supercolonization in the ciprofloxacin group with Candida parapsilosis. In the combined antibiotic group, there were 7 persistencies of which 5 were P. aeruginosa. No adverse effects were noted in either group. Treatment was assessed as a complete success in 14/16 and 5/14 cases, partial success in 2/16 and 4/14 cases and unsuccessful or indeterminate in 0/16 and 5/14 cases, respectively. Ciprofloxacin thus appears to be a useful and effective agent in the local therapy of otitis externa.

摘要

30例外耳道炎患者纳入一项前瞻性、随机、平行组对照研究。使用的治疗方案为环丙沙星(2mg/ml)耳滴剂,每日2次,或含土霉素(5mg/ml)、多粘菌素B(10000单位/ml)和氢化可的松(15mg/ml)的滴剂,每日2次,共7天。通过临床体征和症状、治疗开始前及开始后3天和8天耳拭子的细菌学检查结果进行评估,必要时进行长期随访。环丙沙星组纳入16例患者,联合抗生素组纳入14例患者。16例初始拭子中的6例和14例中的7例分别含有铜绿假单胞菌。环丙沙星组3例患者发现革兰氏阴性菌和革兰氏阳性菌混合病原体。所有革兰氏阴性菌分离株对环丙沙星敏感。微生物学评估显示,环丙沙星组所有细菌病原体均迅速根除,1例白色念珠菌持续存在,但同一耳中的金黄色葡萄球菌根除,临床有明显改善。环丙沙星组有1例近平滑念珠菌超定植。联合抗生素组有7例持续存在,其中5例为铜绿假单胞菌。两组均未观察到不良反应。治疗评估为完全成功的分别为14/16和5/14例,部分成功的分别为2/16和4/14例,不成功或不确定的分别为0/16和5/14例。因此,环丙沙星似乎是外耳道炎局部治疗中一种有用且有效的药物。

相似文献

1
Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.外耳道炎:局部使用环丙沙星与局部使用土霉素、多粘菌素B、氢化可的松联合治疗的临床比较
Curr Med Res Opin. 1993;13(3):182-6. doi: 10.1185/03007999309111548.
2
Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.环丙沙星/地塞米松与新霉素/多粘菌素B/氢化可的松治疗急性外耳道炎细菌学治疗失败的差异:一项联合分析的结果
Curr Med Res Opin. 2009 Feb;25(2):287-91. doi: 10.1185/03007990802603072.
3
Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.两项临床试验的汇总分析,比较了环丙沙星/地塞米松耳用混悬液与多粘菌素B/新霉素/氢化可的松耳用混悬液治疗成人和儿童急性外耳道炎的临床疗效。
Clin Ther. 2007 Sep;29(9):1950-6. doi: 10.1016/j.clinthera.2007.09.005.
4
Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.外用环丙沙星/地塞米松与新霉素/多粘菌素B/氢化可的松治疗外耳道炎的疗效和安全性比较
Curr Med Res Opin. 2004 Aug;20(8):1175-83. doi: 10.1185/030079902125004312.
5
Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.0.2%环丙沙星耳用溶液与多粘菌素B-新霉素-氢化可的松治疗急性弥漫性外耳道炎的疗效及安全性比较*
Curr Med Res Opin. 2008 Dec;24(12):3531-42. doi: 10.1185/03007990802583845.
6
Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.外耳道炎临床试验中分离出的病原体对新霉素和多粘菌素B的敏感性下降。
South Med J. 2004 May;97(5):465-71. doi: 10.1097/00007611-200405000-00010.
7
A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis.
Arch Otorhinolaryngol. 1985;242(2):135-9. doi: 10.1007/BF00454412.
8
Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.每日一次的氧氟沙星耳用溶液与每日四次的硫酸新霉素/硫酸多粘菌素B/氢化可的松耳用混悬液对比:一项多中心、随机、评估者盲法试验,比较小儿外耳道炎患者的疗效、安全性及疼痛缓解情况。
Curr Med Res Opin. 2006 Sep;22(9):1725-36. doi: 10.1185/030079906X121057.
9
A clinical comparison of hydrocortisone butyrate with oxytetracycline/hydrocortisone acetate-polymyxin B in the local treatment of acute external otitis.
Eur Arch Otorhinolaryngol. 1990;247(2):77-80. doi: 10.1007/BF00183171.
10
The use of otic powder in the treatment of acute external otitis.耳粉在急性外耳道炎治疗中的应用。
Am J Otolaryngol. 2002 May-Jun;23(3):142-7. doi: 10.1053/ajot.2002.123461.

引用本文的文献

1
Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution.使用环丙沙星滴耳液 0.2% 抗生素治疗急性外耳炎。
Ther Clin Risk Manag. 2011;7:325-36. doi: 10.2147/TCRM.S6769. Epub 2011 Jul 27.
2
Topical treatment of acute otitis externa: clinical comparison of an antibiotics ointment alone or in combination with hydrocortisone acetate.急性外耳道炎的局部治疗:单独使用抗生素软膏或与醋酸氢化可的松联合使用的临床比较。
Eur Arch Otorhinolaryngol. 2007 Sep;264(9):1087-94. doi: 10.1007/s00405-007-0314-0. Epub 2007 May 15.